Viewing Study NCT00449826



Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00449826
Status: COMPLETED
Last Update Posted: 2012-01-26
First Post: 2007-03-20

Brief Title: Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography REACT
Sponsor: Ottawa Heart Institute Research Corporation
Organization: Ottawa Heart Institute Research Corporation

Study Overview

Official Title: Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography REACT
Status: COMPLETED
Status Verified Date: 2012-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this project is to examine the effectiveness of computed tomographic angiography CTA in patients with non-ST elevation acute coronary syndrome NSTE-ACS People who are hospitalized with this situation often require an angiogram to assess the heart and its arteries

Recent advancements in technology have enabled CTA to clearly define coronary artery anatomy with great accuracy and to guide treatment strategies in select patient populations We are investigating that CTA may be used as an alternative to conventional angiograms for the risk stratification of patients with high risk NSTE-ACS

Patients eligible for the study will be high risk NSTE-ACS and awaiting an angiogram Enrolled patients will undergo CTA prior to the angiogram With each CTA the patient will be injected with a small dose of an X-ray dye and will be asked to lie still on the scanning bed for a period of 5-10 minutes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None